216 related articles for article (PubMed ID: 10523870)
1. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods.
Kassa J; Cabal J
Hum Exp Toxicol; 1999 Sep; 18(9):560-5. PubMed ID: 10523870
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods.
Kassa J; Cabal J
Toxicology; 1999 Feb; 132(2-3):111-8. PubMed ID: 10433374
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
J Toxicol Environ Health A; 2005 Apr; 68(8):677-86. PubMed ID: 15901095
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Kassa J
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats.
Kassa J
Hum Exp Toxicol; 1998 Jun; 17(6):331-5. PubMed ID: 9688357
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods.
Kassa J; Cabal J
Pharmacol Toxicol; 1999 Jan; 84(1):41-5. PubMed ID: 9974189
[TBL] [Abstract][Full Text] [Related]
12. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
13. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
19. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
[TBL] [Abstract][Full Text] [Related]
20. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
Jun D; Kuca K; Picha J; Koleckar V; Marek J
Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
